Daniel R. Chard - 13 Mar 2025 Form 4 Insider Report for MEDIFAST INC (MED)

Signature
/s/ Jason L. Groves, attorney-in-fact
Issuer symbol
MED
Transactions as of
13 Mar 2025
Net transactions value
-$109,272
Form type
4
Filing time
18 Mar 2025, 21:26:39 UTC
Previous filing
11 Feb 2025
Next filing
27 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Tax liability $69,364 -5,001 -8.5% $13.87 54,101 13 Mar 2025 Direct F1
transaction MED Common Stock Tax liability $13,159 -944 -1.7% $13.94 53,157 16 Mar 2025 Direct F1
transaction MED Common Stock Tax liability $26,748 -1,864 -3.5% $14.35 51,293 17 Mar 2025 Direct F1
holding MED Common Stock 149,317 13 Mar 2025 The Dan and Allyson Family Irrevocable Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares withheld by the Issuer upon the vesting of a restricted stock unit grant to cover the executive's withholding tax associated with the satisfaction of all vesting conditions. The number of shares withheld is based upon the closing price of a share of Medifast common stock on the vesting date, or if the vesting date fell on a weekend or market holiday, upon the closing price of a share of Medifast common stock on the most recent prior market day.
F2 These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.